HoperTM PTCA balloon dilatation catheter - Angioplasty catheter, balloon dilatation, coronary, basic
Australia TGA ARTG Registered Device · Pure Sponsor Pty Ltd · Lepu Medical Technology Beijing Co Ltd · Class III · Started May 18, 2011
Good Name: Pure Sponsor Pty Ltd - HoperTM PTCA balloon dilatation catheter - Angioplasty catheter, balloon dilatation, coronary, basic
- Risk Class
- Class III
- Product Type
- Single Device Product
- ARTG Category
- General
- Start Date
- May 18, 2011
- Effective Date
- May 18, 2011
- Country
- China
- Address
- Building 7-1 No37 Chaoqian Road, Changping District, Beijing, 102200
• The balloon dilatation catheter is indicated for balloon dilatation of the stenotic portion of a coronary artery or bypass graft stenosis for the purpose of improving myocardial perfusion. • The balloon dilatation catheter is also indicated for post-delivery expansion of balloon expandable stents.
Access comprehensive regulatory information for HoperTM PTCA balloon dilatation catheter - Angioplasty catheter, balloon dilatation, coronary, basic in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is sponsored by Pure Sponsor Pty Ltd, manufactured by Lepu Medical Technology Beijing Co Ltd in China. The device registration started on May 18, 2011.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.